NASDAQ: CBAY

Monday, November 25th was a tough day for CymaBay Therapeutics (NASDAQ: CBAY). The stock crashed by 76.04% to close the day at $1.33. The market reacted this way after the company announced that, it had closed two studies and stopped a third